Skip to main content

Advertisement

Log in

Preoperative computed tomography-assessed sarcopenia as a predictor of complications and long-term prognosis in patients with colorectal cancer: a systematic review and meta-analysis

  • Systematic Reviews and Meta-analyses
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

The relationship between computed tomography (CT)-assessed sarcopenia and colorectal cancer (CRC) prognosis varies in different studies. This systematic review aimed to examine the impact of preoperative CT-assessed sarcopenia on complications and long-term survival in CRC patients.

Methods

The PubMed, Web of Science, Cochrane Library, and Embase databases were searched for relevant literature up to September 10, 2020. Data and characteristics for each study were extracted. Long-term outcomes were assessed using a comprehensive HR with a 95% CI. Complications were assessed using a comprehensive OR with 95% CI. The heterogeneity and publication bias were also investigated, and subgroup and sensitivity analyses were performed.

Results

A total of 19 studies comprising 15,889 patients were included. The comprehensive results demonstrated that sarcopenia is significantly associated with overall survival of CRC patients (HR = 1.40, 95% CI = 1.25–1.58, p < 0.001). Patients with sarcopenia have a higher risk of complications compared to those without sarcopenia. In addition, sarcopenia is strongly associated with poor cancer-specific survival (HR = 1.49, 95% CI = 1.32–1.68, p < 0.001) and disease-free survival (HR = 1.59, 95% CI = 1.32–1.92, p < 0.001) in CRC patients. There is no significant relationship between sarcopenia and recurrence-free survival (HR = 1.32, 95% CI = 0.92–1.89, p = 0.126).

Conclusions

Preoperative CT-assessed sarcopenia can be employed as an effective predictor of complications and long-term prognosis in CRC patients. Standardization of CT-assessed sarcopenia requires comprehensive consideration of race, muscle mass index, body mass index, and gender.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

All datasets presented in this study are included in the article.

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

    Article  PubMed  Google Scholar 

  2. Siegel RL, Miller KD, Sauer AG, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A (2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70(3):145–164. https://doi.org/10.3322/caac.21601

    Article  PubMed  Google Scholar 

  3. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH et al (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271–289

    Article  PubMed  Google Scholar 

  4. Yang Z, Zhou X, Ma B, Xing Y (2018) Predictive value of preoperative sarcopenia in patients with gastric cancer: a meta-analysis and systematic review. J Gastrointest Surg 22(11):1890–1902

    Article  PubMed  Google Scholar 

  5. Bundred J, Kamarajah SK, Roberts KJ (2019) Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis. HPB (Oxford) 21(12):1603–1612

    Article  Google Scholar 

  6. Yang M, Shen Y, Tan L, Li W (2019) Prognostic value of sarcopenia in lung cancer: a systematic review and meta-analysis. Chest 156(1):101–111

    Article  PubMed  Google Scholar 

  7. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423

    Article  PubMed  PubMed Central  Google Scholar 

  8. Paddon-Jones D, Short KR, Campbell WW, Volpi E, Wolfe RR (2008) Role of dietary protein in the sarcopenia of aging. Am J Clin Nutr 87(5):1562s-s1566

    Article  CAS  PubMed  Google Scholar 

  9. Sayer AA, Dennison EM, Syddall HE, Jameson K, Martin HJ, Cooper C (2008) The developmental origins of sarcopenia: using peripheral quantitative computed tomography to assess muscle size in older people. J Gerontol A Biol Sci Med Sci 63(8):835–840

    Article  PubMed  Google Scholar 

  10. Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML et al (2017) Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol 3(12):e172319

    Article  PubMed  Google Scholar 

  11. Dolan RD, Almasaudi AS, Dieu LB, Horgan PG, McSorley ST, McMillan DC (2019) The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer. J Cachexia Sarcopenia Muscle 10(1):111–122

    Article  PubMed  Google Scholar 

  12. Xie H, Gong Y, Kuang J, Yan L, Ruan G, Tang S et al (2020) Computed tomography-determined sarcopenia is a useful imaging biomarker for predicting postoperative outcomes in elderly colorectal cancer patients. Cancer Res Treat 52(3):957–972

    Article  PubMed  PubMed Central  Google Scholar 

  13. Wang S, Xie H, Gong Y, Kuang J, Yan L, Ruan G et al (2020) The value of L3 skeletal muscle index in evaluating preoperative nutritional risk and long-term prognosis in colorectal cancer patients. Sci Rep 10(1):8153

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. van Vugt JLA, Coebergh van den Braak RRJ, Lalmahomed ZS, Vrijland WW, Dekker JWT, Zimmerman DDE et al (2018) Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer. Eur J Surg Oncol 44(9):1354–1360

    Article  PubMed  Google Scholar 

  15. Sun G, Li Y, Peng Y, Lu D, Zhang F, Cui X et al (2018) Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis. Int J Colorectal Dis 33(10):1419–1427

    Article  PubMed  Google Scholar 

  16. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372:n71

    Article  PubMed  PubMed Central  Google Scholar 

  17. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16

    Article  PubMed  PubMed Central  Google Scholar 

  18. Huang DD, Wang SL, Zhuang CL, Zheng BS, Lu JX, Chen FF et al (2015) Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis 17(11):O256–O264

    Article  PubMed  Google Scholar 

  19. Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J et al (2015) Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 22(8):2663–2668

    Article  PubMed  Google Scholar 

  20. Malietzis G, Currie A, Athanasiou T, Johns N, Anyamene N, Glynne-Jones R et al (2016) Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg 103(5):572–580

    Article  CAS  PubMed  Google Scholar 

  21. Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E et al (2017) Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev 26(7):1008–1015

    Article  PubMed  PubMed Central  Google Scholar 

  22. Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML et al (2017) Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol 3(12):e172319

    Article  PubMed  Google Scholar 

  23. Chen W-Z, Chen X-D, Ma L-L, Zhang F-M, Lin J, Zhuang C-L et al (2018) Impact of visceral obesity and sarcopenia on short-term outcomes after colorectal cancer surgery. Dig Dis Sci 63(6):1620–1630

    Article  PubMed  Google Scholar 

  24. Nakanishi R, Oki E, Sasaki S, Hirose K, Jogo T, Edahiro K et al (2018) Sarcopenia is an independent predictor of complications after colorectal cancer surgery. Surg Today 48(2):151–157

    Article  PubMed  Google Scholar 

  25. Sueda T, Takahasi H, Nishimura J, Hata T, Matsuda C, Mizushima T et al (2018) Impact of low muscularity and myosteatosis on long-term outcome after curative colorectal cancer surgery: a propensity score–matched analysis. Dis Colon Rectum 61(3):364–374

    Article  PubMed  Google Scholar 

  26. van Vugt JL, van den Braak RRC, Lalmahomed ZS, Vrijland WW, Dekker JW, Zimmerman DD et al (2018) Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer. Eur J Surg Oncol 44(9):1354–1360

    Article  PubMed  Google Scholar 

  27. Hopkins JJ, Reif RL, Bigam DL, Baracos VE, Eurich DT, Sawyer MB (2019) The impact of muscle and adipose tissue on long-term survival in patients with stage I to III colorectal cancer. Dis Colon Rectum 62(5):549–560

    Article  PubMed  Google Scholar 

  28. Yang J, Zhang T, Feng D, Dai X, Lv T, Wang X et al (2019) A new diagnostic index for sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer. Colorectal Dis 21(5):538–547

    Article  CAS  PubMed  Google Scholar 

  29. Aro R, Mäkäräinen-Uhlbäck E, Ämmälä N, Rautio T, Ohtonen P, Saarnio J, Meriläinen S (2020) The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients – a retrospective register study. Eur J Surg Oncol 46(9):1656–1662. https://doi.org/10.1016/j.ejso.2020.03.206

    Article  PubMed  Google Scholar 

  30. Chen W, Huang Y, Xu L, Shi M, Chen X, Ye G et al (2020) Effects of sarcopenia, hypoalbuminemia, and laparoscopic surgery on postoperative complications in elderly patients with colorectal cancer: a prospective study. Neoplasma 67(4):922–932

    Article  CAS  PubMed  Google Scholar 

  31. Han JS, Ryu H, Park IJ, Kim KW, Shin Y, Kim SO et al (2020) Association of body composition with long-term survival in non-metastatic rectal cancer patients. Cancer Res Treatment 52(2):563

    Article  Google Scholar 

  32. Lee CS, Won DD, Oh SN, Lee YS, Lee IK, Kim IH, Choi MH, Oh ST (2020) Prognostic role of pre-sarcopenia and body composition with long-term outcomes in obstructive colorectal cancer: a retrospective cohort study. World J Surg Oncol 18(1):230. https://doi.org/10.1186/s12957-020-02006-3

  33. Shirdel M, Andersson F, Myte R, Axelsson J, Rutegård M, Blomqvist L, Riklund K, van Guelpen B, Palmqvist R, Gylling B (2020) Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease. Acta Oncol 59(7):799–808. https://doi.org/10.1080/0284186X.2020.1744716

  34. Xiao J, Caan BJ, Feliciano EMC, Meyerhardt JA, Peng PD, Baracos VE et al (2020) Association of low muscle mass and low muscle radiodensity with morbidity and mortality for colon cancer surgery. JAMA Surg 155(10):942. https://doi.org/10.1001/jamasurg.2020.2497

    Article  PubMed  Google Scholar 

  35. Wang S, Xie H, Gong Y, Kuang J, Yan L, Ruan G et al (2020) The value of L3 skeletal muscle index in evaluating preoperative nutritional risk and long-term prognosis in colorectal cancer patients. Sci Rep 10(1):1–11

    CAS  Google Scholar 

  36. Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3(9):565–574

    Article  PubMed  Google Scholar 

  37. Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127(5 Suppl):990S–991S. https://doi.org/10.1093/jn/127.5.990S

  38. Xie H, Gong Y, Kuang J, Yan L, Ruan G, Tang S, Gao F, Gan J (2020) Computed tomography–determined sarcopenia is a useful imaging biomarker for predicting postoperative outcomes in elderly colorectal cancer patients. Cancer Res Treatment 52(3):957–972. https://doi.org/10.4143/crt.2019.695

    Article  Google Scholar 

  39. Zhuang Cheng-Le, Huang Dong-Dong, Pang Wen-Yang, Zhou Chong-Jun, Wang Su-Lin, Lou Neng, Ma Liang-Liang, Zhen Yu, Shen Xian (2016) Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort. Medicine 95(13):e3164. https://doi.org/10.1097/MD.0000000000003164

    Article  PubMed  PubMed Central  Google Scholar 

  40. Simonsen C, Kristensen TS, Sundberg A, Wielsøe S, Christensen J, Hansen CP et al (2021) Assessment of sarcopenia in patients with upper gastrointestinal tumors: prevalence and agreement between computed tomography and dual-energy x-ray absorptiometry. Clin Nutr 40(5):2809–2816

    Article  PubMed  Google Scholar 

  41. Goodpaster BH, Thaete FL, Kelley DE (2000) Composition of skeletal muscle evaluated with computed tomography. Ann N Y Acad Sci 904(1):18–24

    Article  CAS  PubMed  Google Scholar 

  42. Reisinger KW, van Vugt JL, Tegels JJ, Snijders C, Hulsewé KW, Hoofwijk AG et al (2015) Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg 261(2):345–352

    Article  PubMed  Google Scholar 

  43. Wen M-J, Hsieh C-H, Wu C-Z, Hsiao F-C, Hsia T-L, Hung Y-J et al (2013) The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome: a pilot study. Obes Res Clin Pract 7(3):e206–e210

    Article  PubMed  Google Scholar 

  44. Van Vledder M, Levolger S, Ayez N, Verhoef C, Tran T, Ijzermans J (2012) Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99(4):550–557

    Article  PubMed  Google Scholar 

  45. Richards CH, Roxburgh CS, MacMillan MT, Isswiasi S, Robertson EG, Guthrie GK et al (2012) The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PloS one. 7(8):e41883

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Alemán MR, Santolaria F, Batista N, Marıa J, González-Reimers E, Milena A et al (2002) Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine 19(1):21–6

    Article  PubMed  CAS  Google Scholar 

  47. Stene GB, Helbostad JL, Balstad TR, Riphagen II, Kaasa S, Oldervoll LM (2013) Effect of physical exercise on muscle mass and strength in cancer patients during treatment—a systematic review. Crit Rev Oncol Hematol 88(3):573–593

    Article  CAS  PubMed  Google Scholar 

  48. Strasser B, Steindorf K, Wiskemann J, Ulrich CM (2013) Impact of resistance training in cancer survivors: a meta-analysis. Med Sci Sports Exerc 45(11):2080–2090

    Article  PubMed  Google Scholar 

  49. Dallmann R, Weyermann P, Anklin C, Boroff M, Bray-French K, Cardel B et al (2011) The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia. J Cachexia Sarcopenia Muscle 2(3):163–174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Berardi E, Annibali D, Cassano M, Crippa S, Sampaolesi M (2014) Molecular and cell-based therapies for muscle degenerations: a road under construction. Front Physiol 5:119

    Article  PubMed  PubMed Central  Google Scholar 

  51. Lau EM, Lynn HS, Woo JW, Kwok TC, Melton LJ 3rd (2005) Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. J Gerontol A Biol Sci Med Sci 60(2):213–216

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

J.L.G., S.Y.T., H.L.X., and L.S.W. designed this research; M.X.L., G.H.Y., and S.Y.T. performed the statistical analysis; H.L.X. and L.S.W. performed the data extraction, and drafted and revised the manuscript. All authors reviewed and approved the final manuscript.

Corresponding authors

Correspondence to Shuangyi Tang or Jialiang Gan.

Ethics declarations

Ethical approval

This article did not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Considering the nature of this study, informed consent was not required.

Conflict of interest

The authors declare no competing interests.

Additional information

Research registration number

The protocol was registered at PROSPERO: CRD42020216306.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xie, H., Wei, L., Liu, M. et al. Preoperative computed tomography-assessed sarcopenia as a predictor of complications and long-term prognosis in patients with colorectal cancer: a systematic review and meta-analysis. Langenbecks Arch Surg 406, 1775–1788 (2021). https://doi.org/10.1007/s00423-021-02274-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-021-02274-x

Keywords

Navigation